Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNKP | Q96T60 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CCR2 | P41597 | 2/20 | 0.39 |
| ▸ | IDH1 | O75874 | 1/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | IL6ST | P40189 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23600429 | 0.84 | HCRTR1 (0.38) | LMNACCR2IDH1HCRTR1HCRTR2 | |
| SCHEMBL23600430 | 0.83 | LMNA (0.39) | LMNACCR2IDH1HCRTR1HCRTR2 | |
| SCHEMBL23600545 | 0.79 | PNKP (0.46) | PNKPLMNACCR2 | |
| SCHEMBL27888833 | 0.79 | PNKP (0.46) | PNKPLMNACCR2 | |
| SCHEMBL21584022 | 0.78 | IL6ST (0.44) | IDH1IL6STPIK3CD | |
| SCHEMBL21584027 | 0.78 | IL6ST (0.44) | IDH1IL6STPIK3CD | |
| SCHEMBL21582049 | 0.76 | IL6ST (0.42) | IDH1IL6STPIK3CD | |
| SCHEMBL4309720 | 0.74 | PIK3CD (0.43) | IDH1HCRTR1HCRTR2IL6STPIK3CD | |
| SCHEMBL21582034 | 0.73 | EHMT2 (0.42) | IDH1HCRTR1HCRTR2IL6STPIK3CD | |
| SCHEMBL21582036 | 0.73 | EHMT2 (0.42) | IDH1HCRTR1HCRTR2IL6STPIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210198192-A1 | METHODS FOR PREPARING FLORFENIOL AND INTERMEDIATE THEREOF | HEADING (NANJING) PHARMTECHNOLOGIES CO., LTD. (CN) | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198192-A1 | METHODS FOR PREPARING FLORFENIOL AND INTERMEDIATE THEREOF | CYP4F3, CYP4F11, CYP2F1 | PNKP 3217/4885LMNA 1334/4885CCR2 1452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.